Contribution of Automated Technologies to Ion Channel Drug Discovery.

Automated technologies are now resolving the historical relegation that ion channels have endured as targets for the new drug discovery and development global efforts. The richness and adequacy of functional assay methodologies, remarkably fluorescence-based detection of ions fluxes and patch-clamp electrophysiology recording of ionic currents, are now automated and increasingly employed for the analysis of ion channel activity. While the former is currently the most commonly applied, the latter is finally reaching the throughput capacity to be engaged in the primary screening of chemical libraries conformed by hundreds of thousands of compounds. The use of automated instrumentation for the study of ion channel functionality (and dysfunctionality), particularly in the search for novel pharmacological agents with therapeutic purposes, has now reached out beyond the industrial setting, its original natural enclave, and is making its way into a growing number of academic labs and core facilities. The present chapter reviews the increasing contributions accomplished by a variety of different key automated technologies which have revolutionized the strategies to approach the discovery and development of new drugs targeting ion channels.

[1]  Georg C Terstappen,et al.  Ion channel screening technologies today. , 2005, Drug discovery today. Technologies.

[2]  Christine Leisgen,et al.  Automated higher-throughput compound screening on ion channel targets based on the Xenopus laevis oocyte expression system. , 2004, Assay and drug development technologies.

[3]  Predicting changes in cardiac myocyte contractility during early drug discovery with in vitro assays. , 2014, Toxicology and applied pharmacology.

[4]  N. Fertig,et al.  Minimized cell usage for stem cell-derived and primary cells on an automated patch clamp system. , 2013, Journal of pharmacological and toxicological methods.

[5]  D. Vasilyev,et al.  A Novel High-Throughput Screening Assay for HCN Channel Blocker Using Membrane Potential-Sensitive Dye and FLIPR , 2009, Journal of biomolecular screening.

[6]  D. Malan,et al.  Scalable Electrophysiological Investigation of iPS Cell-Derived Cardiomyocytes Obtained by a Lentiviral Purification Strategy , 2015, Journal of clinical medicine.

[7]  Christine Leisgen,et al.  The roboocyte: automated electrophysiology based on Xenopus oocytes. , 2007, Methods in molecular biology.

[8]  Christine Williams,et al.  Patch clamping by numbers. , 2004, Drug discovery today.

[9]  Christophe Py,et al.  From Understanding Cellular Function to Novel Drug Discovery: The Role of Planar Patch-Clamp Array Chip Technology , 2011, Front. Pharmacol..

[10]  Ralf Kettenhofen,et al.  State-of-the-Art Automated Patch Clamp Devices: Heat Activation, Action Potentials, and High Throughput in Ion Channel Screening , 2011, Front. Pharmacol..

[11]  Alan Finkel,et al.  Population Patch Clamp Improves Data Consistency and Success Rates in the Measurement of Ionic Currents , 2006, Journal of biomolecular screening.

[12]  Ion channels in drug discovery and development. , 2003, Drug discovery today.

[13]  Lorenz M Mayr,et al.  Novel trends in high-throughput screening. , 2009, Current opinion in pharmacology.

[14]  Bharath Balasubramanian,et al.  Halide ion effects on human Ether-à-go-go related gene potassium channel properties. , 2013, Assay and drug development technologies.

[15]  O. McManus,et al.  Identification of Novel and Selective KV2 Channel Inhibitors , 2011, Molecular Pharmacology.

[16]  Michael George,et al.  Characterizing Human Ion Channels in Induced Pluripotent Stem Cell–Derived Neurons , 2012, Journal of biomolecular screening.

[17]  Mark L Dallas,et al.  Robotic multiwell planar patch-clamp for native and primary mammalian cells , 2009, Nature Protocols.

[18]  Mohamed Chahine,et al.  New Insights into Cardiac and Brain Sodium Channels Modulation by Beta Blockers , 2011, Front. Pharmacol..

[19]  A Brüggemann,et al.  High quality ion channel analysis on a chip with the NPC technology. , 2003, Assay and drug development technologies.

[20]  R. Papke,et al.  Working with OpusXpress: methods for high volume oocyte experiments. , 2010, Methods.

[21]  Soo Sen Lee,et al.  Flux assays in high throughput screening of ion channels in drug discovery. , 2003, Assay and drug development technologies.

[22]  L. Botana,et al.  Indole alkaloids from the Marquesan plant Rauvolfia nukuhivensis and their effects on ion channels. , 2015, Phytochemistry.

[23]  Ruili Huang,et al.  Identification of quaternary ammonium compounds as potent inhibitors of hERG potassium channels. , 2011, Toxicology and applied pharmacology.

[24]  G. Kaczorowski,et al.  A high-capacity membrane potential FRET-based assay for NaV1.8 channels. , 2006, Assay and drug development technologies.

[25]  Lei Wu,et al.  Ion-channel assay technologies: quo vadis? , 2001, Drug discovery today.

[26]  A. George.  Lessons learned from genetic testing for channelopathies , 2014, The Lancet Neurology.

[27]  O. Krishtal,et al.  Effect of internal fluoride and phosphate on membrane currents during intracellular dialysis of nerve cells , 1975, Nature.

[28]  Clare,et al.  Voltage-gated sodium channels as therapeutic targets. , 2000, Drug discovery today.

[29]  Michael Fejtl,et al.  The roboocyte: automated cDNA/mRNA injection and subsequent TEVC recording on Xenopus oocytes in 96-well microtiter plates. , 2003, Receptors & channels.

[30]  D. Wicks,et al.  Atomic absorption spectroscopy in ion channel screening. , 2004, Assay and drug development technologies.

[31]  D. Mikhailov,et al.  Cardiac ion channel safety profiling on the IonWorks Quattro automated patch clamp system. , 2010, Assay and drug development technologies.

[32]  Vinciguerra,et al.  EXPRESSION AND FUNCTION OF Kv 7 . 4 CHANNELS IN RAT CARDIAC MITOCHONDRIA : POSSIBLE TARGETS FOR CARDIOPROTECTION 1 , 2016 .

[33]  Xiaobo Wang,et al.  Automated electrophysiology: high throughput of art. , 2003, Assay and drug development technologies.

[34]  P. Negulescu,et al.  Characterization of voltage-gated sodium-channel blockers by electrical stimulation and fluorescence detection of membrane potential , 2006, Nature Biotechnology.

[35]  Clemens Möller,et al.  Automated planar patch-clamp. , 2013, Methods in molecular biology.

[36]  Clemens Möller,et al.  Automated Electrophysiology Makes the Pace for Cardiac Ion Channel Safety Screening , 2011, Front. Pharmacol..

[37]  Arthur M. Brown.  High throughput functional screening of an ion channel library for drug safety and efficacy , 2008, European Biophysics Journal.

[38]  Jeffrey J Clare,et al.  Targeting ion channels for drug discovery. , 2010, Discovery medicine.

[39]  Harry J Witchel,et al.  Drug-induced hERG block and long QT syndrome. , 2011, Cardiovascular therapeutics.

[40]  Jesús E González,et al.  Cellular fluorescent indicators and voltage/ion probe reader (VIPR) tools for ion channel and receptor drug discovery. , 2002, Receptors & channels.

[41]  Alfred Stett,et al.  CYTOCENTERING: a novel technique enabling automated cell-by-cell patch clamping with the CYTOPATCH chip. , 2003, Receptors & channels.

[42]  O. McManus,et al.  Ion Channels as Drug Targets: The Next GPCRs , 2008, The Journal of general physiology.

[43]  N. Fertig,et al.  Automated Patch Clamp Analysis of nAChα7 and NaV1.7 Channels , 2014, Current protocols in pharmacology.

[44]  Jing Li,et al.  Interactions, Functions, and Independence of Plasma Membrane STIM1 and TRPC1 in Vascular Smooth Muscle Cells , 2008, Circulation research.

[45]  S. Polak,et al.  Collation, assessment and analysis of literature in vitro data on hERG receptor blocking potency for subsequent modeling of drugs' cardiotoxic properties , 2009, Journal of applied toxicology : JAT.

[46]  C. Ionescu-Zanetti,et al.  Comparison of cell expression formats for the characterization of GABA(A) channels using a microfluidic patch clamp system. , 2012, Assay and drug development technologies.

[47]  A. Mathie.  Ion channels as novel therapeutic targets in the treatment of pain , 2010, The Journal of pharmacy and pharmacology.

[48]  John Comley,et al.  8 years of surveying ion channel screening - has anything changed? , 2011 .

[49]  M. Ferrer,et al.  Miniaturization and HTS of a FRET-based membrane potential assay for K(ir) channel inhibitors. , 2008, Assay and drug development technologies.

[50]  Sven Becker,et al.  Thoughts on the current assessment of Polo-like kinase inhibitor drug discovery , 2015, Expert opinion on drug discovery.

[51]  T. Danker,et al.  Early identification of hERG liability in drug discovery programs by automated patch clamp , 2014, Front. Pharmacol..

[52]  O. McManus.  HTS assays for developing the molecular pharmacology of ion channels. , 2014, Current opinion in pharmacology.

[53]  R. Papke,et al.  High throughput electrophysiology with Xenopus oocytes. , 2009, Combinatorial chemistry & high throughput screening.

[54]  Li Zhiyuan,et al.  A Comparison of the Performance and Application Differences Between Manual and Automated Patch-Clamp Techniques , 2012, Current chemical genomics.

[55]  R. Papke,et al.  Estimation of both the potency and efficacy of alpha7 nAChR agonists from single-concentration responses. , 2006, Life sciences.

[56]  J. Sullivan,et al.  Pharmaceutical Optimization of Peptide Toxins for Ion Channel Targets: Potent, Selective, and Long-Lived Antagonists of Kv1.3. , 2015, Journal of medicinal chemistry.

[57]  Sikander Gill,et al.  Development of an HTS assay for Na+, K+-ATPase using nonradioactive rubidium ion uptake. , 2004, Assay and drug development technologies.

[58]  T. Knott,et al.  Late cardiac sodium current can be assessed using automated patch-clamp , 2014, F1000Research.

[59]  LagruttaArmando,et al.  Halide Ion Effects on Human Ether-à-go-go Related Gene Potassium Channel Properties , 2013 .

[60]  Wei Zheng,et al.  High throughput assay technologies for ion channel drug discovery. , 2004, Assay and drug development technologies.

[61]  S. Trivedi,et al.  Cellular HTS assays for pharmacological characterization of Na(V)1.7 modulators. , 2008, Assay and drug development technologies.

[62]  C. Townsend,et al.  Predicting Drug‐Induced QT Prolongation and Torsades de Pointes: A Review of Preclinical Endpoint Measures , 2013, Current protocols in pharmacology.

[63]  X. Shao,et al.  A new technique for multiple re-use of planar patch clamp chips , 2012, Journal of Neuroscience Methods.

[64]  Zhengyu Cao,et al.  Cardiotoxicity screening: a review of rapid-throughput in vitro approaches , 2015, Archives of Toxicology.

[65]  Renza Roncarati,et al.  Screening technologies for ion channel drug discovery. , 2010, Future medicinal chemistry.

[66]  A. Dubin,et al.  Identifying Modulators of hERG Channel Activity Using the PatchXpress® Planar Patch Clamp , 2005, Journal of biomolecular screening.

[67]  Gary R. Mirams,et al.  Prediction of Thorough QT study results using action potential simulations based on ion channel screens , 2014, Journal of pharmacological and toxicological methods.

[68]  Derek J Trezise,et al.  Population patch clamp electrophysiology: a breakthrough technology for ion channel screening. , 2007, Molecular bioSystems.

[69]  P. Negulescu,et al.  High-throughput screening strategies for cardiac ion channels. , 2001, Trends in cardiovascular medicine.

[70]  Michael F. Finley,et al.  High-Throughput Screen of GluK1 Receptor Identifies Selective Inhibitors with a Variety of Kinetic Profiles Using Fluorescence and Electrophysiology Assays , 2015, Journal of biomolecular screening.

[71]  M. Reed,et al.  Micromolded PDMS planar electrode allows patch clamp electrical recordings from cells. , 2002, Biosensors & bioelectronics.

[72]  Ralf Kettenhofen,et al.  Minimized cell usage for stem cell-derived and primary cells on an automated patch clamp system. , 2013, Journal of pharmacological and toxicological methods.

[73]  Yuji Haraguchi,et al.  Electrophysiological analysis of mammalian cells expressing hERG using automated 384-well-patch-clamp , 2015, BMC Pharmacology and Toxicology.

[74]  J. Licinio,et al.  Chromaffin cells: the peripheral brain , 2012, Molecular Psychiatry.

[75]  Brian A. Chauder,et al.  High-Throughput Screening Reveals a Small-Molecule Inhibitor of the Renal Outer Medullary Potassium Channel and Kir7.1 , 2009, Molecular Pharmacology.

[76]  Chris Mathes,et al.  QPatch: the past, present and future of automated patch clamp , 2006, Expert opinion on therapeutic targets.

[77]  Paul B Bennett,et al.  Trends in ion channel drug discovery: advances in screening technologies. , 2003, Trends in biotechnology.

[78]  Arturo Picones,et al.  Improved Early Detection of HERG Channel Liability in Lead Optimization Programs with Automated Patch-Clamp Technology , 2009 .

[79]  John P. Overington,et al.  How many drug targets are there? , 2006, Nature Reviews Drug Discovery.

[80]  Bryan L Roth,et al.  Identification of human Ether-à-go-go related gene modulators by three screening platforms in an academic drug-discovery setting. , 2010, Assay and drug development technologies.

[81]  Min Li,et al.  High throughput screening technologies for ion channels , 2015, Acta Pharmacologica Sinica.

[82]  Shiu-Nan Chen,et al.  Apoptotic cell: linkage of inflammation and wound healing , 2014, Front. Pharmacol..

[83]  A. Ebneth.  Ion channel screening technologies: will they revolutionize drug discovery? , 2002, Drug discovery today.

[84]  A. Savchenko,et al.  Bright future of optical assays for ion channel drug discovery. , 2008, Drug discovery today.

[85]  P. Emery,et al.  TRPC channel activation by extracellular thioredoxin , 2008, Nature.

[86]  O. Pongs,et al.  Screening lead compounds for QT interval prolongation. , 2001, Drug discovery today.

[87]  Alfred Stett,et al.  CYTOCENTERING: a novel technique enabling automated cell-by-cell patch clamping with the CYTOPATCH chip. , 2003, Receptors & channels.

[88]  V. Warren,et al.  Functional assay of voltage-gated sodium channels using membrane potential-sensitive dyes. , 2004, Assay and drug development technologies.

[89]  Derek J Trezise,et al.  IonWorks™ HT: A New High-Throughput Electrophysiology Measurement Platform , 2003, Journal of biomolecular screening.

[90]  J. Valentin,et al.  Trends in safety pharmacology: posters presented at the annual meetings of the Safety Pharmacology Society 2001-2010. , 2011, Journal of pharmacological and toxicological methods.

[91]  Arturo Picones.  Ion channels as medicinal targets of biological toxins: the impact of automated patch-clamp electrophysiology. , 2015, Current topics in medicinal chemistry.

[92]  G. Kovácsová,et al.  Cell-free expression of a functional pore-only sodium channel , 2015, Protein expression and purification.

[93]  Michael George,et al.  Port-a-patch and patchliner: high fidelity electrophysiology for secondary screening and safety pharmacology. , 2009, Combinatorial chemistry & high throughput screening.

[94]  Markéta Bébarová,et al.  Advances in patch clamp technique: towards higher quality and quantity. , 2012, General physiology and biophysics.

[95]  Philip T Sager,et al.  Finding the rhythm of sudden cardiac death: new opportunities using induced pluripotent stem cell-derived cardiomyocytes. , 2015, Circulation research.

[96]  Jin-feng Yue,et al.  Novel KCNQ2 channel activators discovered using fluorescence-based and automated patch-clamp-based high-throughput screening techniques , 2016, Acta Pharmacologica Sinica.

[97]  John Dunlop,et al.  hERG (KCNH2 or Kv11.1) K+ channels: screening for cardiac arrhythmia risk. , 2008, Current drug metabolism.

[98]  Arturo Picones,et al.  Validation of Automated Patch-Clamp Instrumentation Competency for Herg Channel Liability Detection in Lead Optimization Programs , 2010 .

[99]  Gary R. Mirams,et al.  Variability in high-throughput ion-channel screening data and consequences for cardiac safety assessment , 2013, Journal of pharmacological and toxicological methods.

[100]  Michael George,et al.  Automated ion channel screening: patch clamping made easy , 2007, Expert opinion on therapeutic targets.

[101]  Clay W Scott,et al.  A medium-throughput functional assay of KCNQ2 potassium channels using rubidium efflux and atomic absorption spectrometry. , 2003, Analytical biochemistry.

[102]  David J Beech,et al.  Pregnenolone Sulphate- and Cholesterol-Regulated TRPM3 Channels Coupled to Vascular Smooth Muscle Secretion and Contraction , 2010, Circulation research.

[103]  Suhasa B. Kodandaramaiah,et al.  Automated whole-cell patch clamp electrophysiology of neurons in vivo , 2012, Nature Methods.

[104]  G. Terstappen,et al.  Functional analysis of native and recombinant ion channels using a high-capacity nonradioactive rubidium efflux assay. , 1999, Analytical biochemistry.

[105]  K. Carlin,et al.  N-Aryl azacycles as novel sodium channel blockers. , 2015, Bioorganic & medicinal chemistry letters.

[106]  Tadashi Kimura,et al.  The application of the Escherichia coli giant spheroplast for drug screening with automated planar patch clamp system , 2015, Biotechnology reports.

[107]  N. Fertig,et al.  Ion channel drug discovery and research: the automated Nano-Patch-Clamp technology. , 2004, Current drug discovery technologies.

[108]  Robert H Blick,et al.  Whole cell patch clamp recording performed on a planar glass chip. , 2002, Biophysical journal.

[109]  C. Lindsley,et al.  Development and validation of a thallium flux-based functional assay for the sodium channel NaV1.7 and its utility for lead discovery and compound profiling. , 2015, ACS chemical neuroscience.

[110]  Brian Cox,et al.  HTS approaches to voltage-gated ion channel drug discovery , 1998 .

[111]  S. Dworetzky,et al.  A Thallium-Sensitive, Fluorescence-Based Assay for Detecting and Characterizing Potassium Channel Modulators in Mammalian Cells , 2004, Journal of biomolecular screening.

[112]  Thomas Knott,et al.  Introduction of a modular automated voltage-clamp platform and its correlation with manual human Ether-à-go-go related gene voltage-clamp data. , 2011, Assay and drug development technologies.

[113]  I. Scheffer,et al.  Augmented currents of an HCN2 variant in patients with febrile seizure syndromes , 2010, Annals of neurology.

[114]  P. Chatelain,et al.  Comparative Study of Membrane Potential-Sensitive Fluorescent Probes and their Use in Ion Channel Screening Assays , 2003, Journal of biomolecular screening.

[115]  K. Walsh.  Targeting cardiac potassium channels for state-of-the-art drug discovery , 2015, Expert opinion on drug discovery.

[116]  B. Sakmann,et al.  Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches , 1981, Pflügers Archiv.

[117]  Andreas Ebneth,et al.  Evaluation of a High-Throughput Fluorescence Assay Method for hERG Potassium Channel Inhibition , 2005, Journal of biomolecular screening.

[118]  P. Negulescu,et al.  Cell-based assays and instrumentation for screening ion-channel targets. , 1999, Drug discovery today.

[119]  T. Bridal,et al.  Comparison of human Ether-à-go-go related gene screening assays based on IonWorks Quattro and thallium flux. , 2010, Assay and drug development technologies.

[120]  J. Drews.  Drug discovery: a historical perspective. , 2000, Science.

[121]  Ralf Kettenhofen,et al.  Automated Patch Clamp on mESC-Derived Cardiomyocytes for Cardiotoxicity Prediction , 2011, Journal of biomolecular screening.

[122]  P. Imming,et al.  Drugs, their targets and the nature and number of drug targets , 2006, Nature Reviews Drug Discovery.

[123]  Suhasa B Kodandaramaiah,et al.  Microchip amplifier for in vitro, in vivo, and automated whole cell patch-clamp recording. , 2015, Journal of neurophysiology.

[124]  Niels Fertig,et al.  Planar Patch Clamping , 2007 .

[125]  Y. Wang,et al.  Development and validation of HTS assay for screening the calcium-activated chloride channel modulators in TMEM16A stably expressed CHO cells , 2014, Analytical and Bioanalytical Chemistry.

[126]  R. Peri,et al.  High-throughput electrophysiology: an emerging paradigm for ion-channel screening and physiology , 2008, Nature Reviews Drug Discovery.

[127]  A. Swensen,et al.  A pharmacologically validated, high-capacity, functional thallium flux assay for the human Ether-à-go-go related gene potassium channel. , 2010, Assay and drug development technologies.

[128]  Mark Slack,et al.  Impact of new technologies for cellular screening along the drug value chain. , 2010, Drug discovery today.

[129]  Bogdan Amuzescu,et al.  Action potential characterization of human induced pluripotent stem cell-derived cardiomyocytes using automated patch-clamp technology. , 2014, Assay and drug development technologies.

[130]  Andreas Sewing,et al.  High-Throughput Screening for Ion Channel Modulators , 2002, Journal of biomolecular screening.

[131]  T. Priestley,et al.  Characterization of a hERG screen using the IonWorks HT: comparison to a hERG rubidium efflux screen. , 2005, Assay and drug development technologies.

[132]  Michael George,et al.  Automated Patch Clamp Meets High-Throughput Screening , 2016, Journal of laboratory automation.